Zar-Kessler Claire, Karaa Amel, Sims Katherine Bustin, Clarke Virginia, Kuo Braden
MGH Center for Neurointestinal Health, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Massachusetts General Hospital for Children, 175 Cambridge St CPZ-575, Boston, MA 02114, USA.
Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Therap Adv Gastroenterol. 2016 Jul;9(4):626-34. doi: 10.1177/1756283X16642936. Epub 2016 Apr 15.
Fabry disease is a rare X-linked lysosomal storage disease characterized by the dysfunction of multiple systems, including significant gastrointestinal involvement such as diarrhea, abdominal pain, early satiety and nausea. The gastrointestinal symptoms of Fabry disease are thought to be due to neuropathic and myopathic changes leading to symptoms of dysmotility that are encountered in many other disorders. The gastrointestinal symptoms can often be one of the presenting signs of the disease in childhood, but can be misdiagnosed by gastroenterologists for many years due to their nonspecific presentation. As the chief treatment for Fabry is enzyme-replacement therapy that has been shown to stabilize and possibly reverse disease course, recognition of these symptoms and early diagnosis in an attempt to prevent progression with treatment, is critical.
法布里病是一种罕见的X连锁溶酶体贮积病,其特征是多系统功能障碍,包括严重的胃肠道受累,如腹泻、腹痛、早饱感和恶心。法布里病的胃肠道症状被认为是由于神经病变和肌病变导致的运动障碍症状,这在许多其他疾病中也会出现。胃肠道症状通常可能是儿童期该病的首发症状之一,但由于其表现不具特异性,多年来可能会被胃肠病学家误诊。由于法布里病的主要治疗方法是酶替代疗法,已证明该疗法可稳定并可能逆转疾病进程,因此识别这些症状并尽早诊断以防止疾病进展并进行治疗至关重要。